Brought to you by 
Allergan signs US co-promotion deal with Dura
13 Mar 2000
Executive Summary
In a multi-year deal, respiratory pharmaceuticals company Dura will sell Allergan's (mostly eye care products and some specialty pharmaceuticals) Alocril (nedocromil sodium)--indicated for itching related to allergic conjunctivitis--in the US to respiratory specialists and primary care physicians.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Co-Promotion
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Allergan signs US co-promotion deal with Dura
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice